Cargando…
Utility of risk-weighted surgical–pathological factors in early-stage cervical cancer
BACKGROUND: Surgical–pathological risk factors were evaluated by weighting the magnitude of significance of multiple risk factors correlating to survival and treatment response in cervical cancer. METHODS: Multivariate analysis was performed for survival outcomes entering seven pathological factors...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619265/ https://www.ncbi.nlm.nih.gov/pubmed/23462721 http://dx.doi.org/10.1038/bjc.2013.78 |
_version_ | 1782265483055071232 |
---|---|
author | Matsuo, K Mabuchi, S Okazawa, M Matsumoto, Y Tsutsui, T Fujita, M Kamiura, S Ogawa, K Morrow, C P Kimura, T |
author_facet | Matsuo, K Mabuchi, S Okazawa, M Matsumoto, Y Tsutsui, T Fujita, M Kamiura, S Ogawa, K Morrow, C P Kimura, T |
author_sort | Matsuo, K |
collection | PubMed |
description | BACKGROUND: Surgical–pathological risk factors were evaluated by weighting the magnitude of significance of multiple risk factors correlating to survival and treatment response in cervical cancer. METHODS: Multivariate analysis was performed for survival outcomes entering seven pathological factors obtained from 540 radical hysterectomy specimens in stage IA2-IIB cervical cancer cases. Hazard ratio (HR) in each risk factor was determined, and the sum of HR scores for the corresponding risk factors was determined per case. Survival curves and postoperative treatment response (concurrent chemoradiotherapy (CCRT) vs radiotherapy alone) were evaluated based on the extent of HR-weighted scores. RESULTS: Hazard ratios for risk factors relating to disease-free survival (DFS) was: lympho-vascular space invasion 3.95, nodal metastasis 3.88, adenocarcinoma 3.40, large tumour 2.36, positive margin 1.99, deep stromal invasion 1.29, and parametria invasion 1.21. The HR-weighted scoring method showed a high predictive value for recurrence (area-under-curve 0.836, P<0.001). Hazard ratio-weighted scores were negatively correlated to DFS, and the cases with score ⩾12.5 showed 5-year DFS rate of 23.8%. Tumours with larger score offset the benefits of CCRT over radiotherapy alone for postoperative adjuvant treatment (P<0.001). CONCLUSION: Surgical–pathological risk factors provide valuable information for survival and management of early-stage cervical cancer when number and significance of risks are weighted. |
format | Online Article Text |
id | pubmed-3619265 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-36192652014-04-02 Utility of risk-weighted surgical–pathological factors in early-stage cervical cancer Matsuo, K Mabuchi, S Okazawa, M Matsumoto, Y Tsutsui, T Fujita, M Kamiura, S Ogawa, K Morrow, C P Kimura, T Br J Cancer Molecular Diagnostics BACKGROUND: Surgical–pathological risk factors were evaluated by weighting the magnitude of significance of multiple risk factors correlating to survival and treatment response in cervical cancer. METHODS: Multivariate analysis was performed for survival outcomes entering seven pathological factors obtained from 540 radical hysterectomy specimens in stage IA2-IIB cervical cancer cases. Hazard ratio (HR) in each risk factor was determined, and the sum of HR scores for the corresponding risk factors was determined per case. Survival curves and postoperative treatment response (concurrent chemoradiotherapy (CCRT) vs radiotherapy alone) were evaluated based on the extent of HR-weighted scores. RESULTS: Hazard ratios for risk factors relating to disease-free survival (DFS) was: lympho-vascular space invasion 3.95, nodal metastasis 3.88, adenocarcinoma 3.40, large tumour 2.36, positive margin 1.99, deep stromal invasion 1.29, and parametria invasion 1.21. The HR-weighted scoring method showed a high predictive value for recurrence (area-under-curve 0.836, P<0.001). Hazard ratio-weighted scores were negatively correlated to DFS, and the cases with score ⩾12.5 showed 5-year DFS rate of 23.8%. Tumours with larger score offset the benefits of CCRT over radiotherapy alone for postoperative adjuvant treatment (P<0.001). CONCLUSION: Surgical–pathological risk factors provide valuable information for survival and management of early-stage cervical cancer when number and significance of risks are weighted. Nature Publishing Group 2013-04-02 2013-03-05 /pmc/articles/PMC3619265/ /pubmed/23462721 http://dx.doi.org/10.1038/bjc.2013.78 Text en Copyright © 2013 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ |
spellingShingle | Molecular Diagnostics Matsuo, K Mabuchi, S Okazawa, M Matsumoto, Y Tsutsui, T Fujita, M Kamiura, S Ogawa, K Morrow, C P Kimura, T Utility of risk-weighted surgical–pathological factors in early-stage cervical cancer |
title | Utility of risk-weighted surgical–pathological factors in early-stage cervical cancer |
title_full | Utility of risk-weighted surgical–pathological factors in early-stage cervical cancer |
title_fullStr | Utility of risk-weighted surgical–pathological factors in early-stage cervical cancer |
title_full_unstemmed | Utility of risk-weighted surgical–pathological factors in early-stage cervical cancer |
title_short | Utility of risk-weighted surgical–pathological factors in early-stage cervical cancer |
title_sort | utility of risk-weighted surgical–pathological factors in early-stage cervical cancer |
topic | Molecular Diagnostics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619265/ https://www.ncbi.nlm.nih.gov/pubmed/23462721 http://dx.doi.org/10.1038/bjc.2013.78 |
work_keys_str_mv | AT matsuok utilityofriskweightedsurgicalpathologicalfactorsinearlystagecervicalcancer AT mabuchis utilityofriskweightedsurgicalpathologicalfactorsinearlystagecervicalcancer AT okazawam utilityofriskweightedsurgicalpathologicalfactorsinearlystagecervicalcancer AT matsumotoy utilityofriskweightedsurgicalpathologicalfactorsinearlystagecervicalcancer AT tsutsuit utilityofriskweightedsurgicalpathologicalfactorsinearlystagecervicalcancer AT fujitam utilityofriskweightedsurgicalpathologicalfactorsinearlystagecervicalcancer AT kamiuras utilityofriskweightedsurgicalpathologicalfactorsinearlystagecervicalcancer AT ogawak utilityofriskweightedsurgicalpathologicalfactorsinearlystagecervicalcancer AT morrowcp utilityofriskweightedsurgicalpathologicalfactorsinearlystagecervicalcancer AT kimurat utilityofriskweightedsurgicalpathologicalfactorsinearlystagecervicalcancer |